BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21809065)

  • 1. [Intermittent fever under iatrogenic immunosuppression].
    Bönstrup M; Schmiedel S; Lohse AW
    Internist (Berl); 2012 Feb; 53(2):213-7. PubMed ID: 21809065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months' follow-up.
    Rothenburger M; Teerling E; Bruch C; Lehmkuhl H; Suwelack B; Bara C; Wichter T; Hinder F; Schmid C; Stypmann J
    J Heart Lung Transplant; 2007 Mar; 26(3):250-7. PubMed ID: 17346627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Everolimus-induced drug fever after heart transplantation.
    Dorschner L; Speich R; Ruschitzka F; Seebach JD; Gallino A
    Transplantation; 2004 Jul; 78(2):303-4. PubMed ID: 15280699
    [No Abstract]   [Full Text] [Related]  

  • 4. Fever of unknown origin (FUO) in a renal transplant recipient due to drug fever from sirolimus.
    Sharif S; Kong MW; Drakakis J; Cunha BA
    Infection; 2016 Aug; 44(4):559-61. PubMed ID: 26830785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus and everolimus induced pneumonitis in adult renal allograft recipients: experience in a center.
    Rodríguez-Moreno A; Ridao N; García-Ledesma P; Calvo N; Pérez-Flores I; Marques M; Barrientos A; Sánchez-Fructuoso AI
    Transplant Proc; 2009; 41(6):2163-5. PubMed ID: 19715862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unexplained fever and B-symptoms in a young male Black African].
    Weber T; Ettrich T; Christopeit M; Lindner A; Holzhausen HJ; Oehme A; Arnold D; Wolf HH; Lübbert C; Kekulé AS; Schmoll HJ; Werdan K; Ebelt H
    Internist (Berl); 2012 Jan; 53(1):93-8. PubMed ID: 21953027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of sirolimus-induced pneumonitis after conversion to everolimus.
    Rehm B; Keller F; Mayer J; Stracke S
    Transplant Proc; 2006 Apr; 38(3):711-3. PubMed ID: 16647451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.
    Webster AC; Lee VW; Chapman JR; Craig JC
    Cochrane Database Syst Rev; 2006 Apr; (2):CD004290. PubMed ID: 16625599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Everolimus-associated pneumonitis in adult liver transplant recipient].
    Marín-Gómez LM; Cordero-Matía E; Gómez-Bravo MÁ; Bernal-Bellido C
    Med Clin (Barc); 2010 Sep; 135(9):431-2. PubMed ID: 19819477
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pneumonitis caused by sirolimus: improvement after switching to everolimus].
    Calle L; Tejada C; Lancho C; Mazuecos A
    Nefrologia; 2009; 29(5):490-1. PubMed ID: 19820768
    [No Abstract]   [Full Text] [Related]  

  • 11. Everolimus-related organizing pneumonia: a report establishing causality.
    Frija J; Joly D; Knebelmann B; Dusser D; Burgel PR
    Invest New Drugs; 2012 Jun; 30(3):1244-7. PubMed ID: 21188465
    [No Abstract]   [Full Text] [Related]  

  • 12. Pregnancy under everolimus-based immunosuppression.
    Veroux M; Corona D; Veroux P
    Transpl Int; 2011 Dec; 24(12):e115-7. PubMed ID: 21950359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Everolimus-related pulmonary toxicity in heart transplant recipients.
    Expósito V; de Prada JA; Gómez-Román JJ; González-Vilchez F; Llano-Cardenal M; García-Camarero T; Fernández-Valls M; Ruano J; Martín-Durán R
    J Heart Lung Transplant; 2008 Jul; 27(7):797-800. PubMed ID: 18582812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with everolimus (Certican): a summary.
    Ponticelli C
    Transplantation; 2005 May; 79(9 Suppl):S93-4. PubMed ID: 15880024
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interstitial pneumonitis from everolimus].
    Losada González GP; Gómez Marqués G; Martínez Mateu JG; Munar Vila MA; Uriol Rivera M
    Nefrologia; 2010; 30(4):479-80. PubMed ID: 20651895
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years' follow-up from the University Hospital Münster.
    Stypmann J; Engelen MA; Eckernkemper S; Amler S; Gunia S; Sindermann JR; Rothenburger M; Rukosujew A; Drees G; Welp HA
    Transplant Proc; 2011 Jun; 43(5):1847-52. PubMed ID: 21693288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second episode of near-fatal angioedema in a patient treated with everolimus.
    Andersen LK; Jensen JE; Bygum A
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):152-3. PubMed ID: 26081314
    [No Abstract]   [Full Text] [Related]  

  • 18. Everolimus-associated pneumonitis in 3 heart transplant recipients.
    Otton J; Hayward CS; Keogh AM; Glanville AR; Macdonald PS
    J Heart Lung Transplant; 2009 Jan; 28(1):104-6. PubMed ID: 19134540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infective endocarditis in two patients with pemphigus vulgaris under multiagent immunosuppressive drug therapy: A rare entity to remember in the differential diagnosis of fever of unknown origin.
    Küçükoğlu R; Kılıç S; Sun GP
    Dermatol Ther; 2019 May; 32(3):e12860. PubMed ID: 30758911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic thrombocytopenic purpura associated with everolimus use in a renal transplant patient.
    Yılmaz VT; Koçak H; Avcı AB; Salim O; Ersoy FF; Süleymanlar G
    Int Urol Nephrol; 2011 Jun; 43(2):581-4. PubMed ID: 20495869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.